• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谷胱甘肽S-转移酶T1:膀胱癌侵袭性的一个标志物。

GSTT1: a marker of the aggressiveness of bladder cancer.

作者信息

Ha Yun-Sok, Yan Chunri, Park Cheol, Yun Seok-Joong, Moon Sung-Kwon, Choi Yung Hyun, Kim Wun-Jae

机构信息

Department of Urology, College of Medicine, Chungbuk National University, Cheongju, South Korea.

出版信息

Urol Int. 2011;86(1):41-6. doi: 10.1159/000321689. Epub 2010 Nov 16.

DOI:10.1159/000321689
PMID:21079384
Abstract

INTRODUCTION

Glutathione S-transferases have been implicated in the development of bladder cancer (BC). We investigated the genotype and expression of glutathione S-transferase-mu (GSTM1) and glutathione S-transferase-theta (GSTT1) in BC tissue specimens.

MATERIALS AND METHODS

Tumor samples and matched normal mucosae were obtained from 34 patients. Genomic DNA was used to analyze GSTM1 and GSTT1 genotypes using multiplex polymerase chain reaction. GSTM1 and GSTT1 mRNA levels were measured using real-time reverse transcriptase polymerase chain reaction.

RESULTS

GSTM1 mRNA expression was lower in tumor tissues than in matched normal bladder mucosae, whereas GSTT1 mRNA expression was significantly higher. GSTT1 mRNA expression was higher in muscle-invasive BC and high-grade cancers than in non-muscle-invasive BC and lower-grade tumors.

CONCLUSIONS

GSTT1 is correlated with characteristics of aggressive BC. GSTT1 may play an important role in tumorigenesis and disease progression in patients with BC.

摘要

引言

谷胱甘肽S-转移酶与膀胱癌(BC)的发生发展有关。我们研究了膀胱癌组织标本中谷胱甘肽S-转移酶-μ(GSTM1)和谷胱甘肽S-转移酶-θ(GSTT1)的基因型和表达情况。

材料与方法

从34例患者获取肿瘤样本及配对的正常黏膜组织。采用多重聚合酶链反应,利用基因组DNA分析GSTM1和GSTT1基因型。使用实时逆转录聚合酶链反应检测GSTM1和GSTT1 mRNA水平。

结果

肿瘤组织中GSTM1 mRNA表达低于配对的正常膀胱黏膜组织,而GSTT1 mRNA表达显著更高。GSTT1 mRNA在肌层浸润性膀胱癌和高级别癌中的表达高于非肌层浸润性膀胱癌和低级别肿瘤。

结论

GSTT1与侵袭性膀胱癌的特征相关。GSTT1可能在膀胱癌患者的肿瘤发生和疾病进展中起重要作用。

相似文献

1
GSTT1: a marker of the aggressiveness of bladder cancer.谷胱甘肽S-转移酶T1:膀胱癌侵袭性的一个标志物。
Urol Int. 2011;86(1):41-6. doi: 10.1159/000321689. Epub 2010 Nov 16.
2
Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients.谷胱甘肽 S-转移酶 M1 和 T1 多态性:在肌肉浸润性膀胱癌患者中的易感性和结局。
Eur J Cancer. 2013 Sep;49(14):3010-9. doi: 10.1016/j.ejca.2013.05.019. Epub 2013 Jun 26.
3
Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.谷胱甘肽 S-转移酶 T1(GSTT1)和谷胱甘肽 S-转移酶 M1(GSTM1)基因多态性缺失与膀胱癌易感性。
BJU Int. 2011 Jun;107(11):1825-32. doi: 10.1111/j.1464-410X.2010.09683.x. Epub 2010 Oct 13.
4
The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non-muscle invasive bladder cancer.谷胱甘肽S-转移酶T1基因多态性对非肌层浸润性膀胱癌患者卡介苗诱导治疗早期反应的预测价值
Urol Oncol. 2014 May;32(4):458-65. doi: 10.1016/j.urolonc.2013.10.013. Epub 2014 Jan 9.
5
Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.谷胱甘肽S-转移酶M1和T1的基因多态性作为肺癌和膀胱癌的一个风险因素。
Neoplasma. 1998;45(5):312-7.
6
Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer.肿瘤坏死因子-α、血管内皮生长因子、人8-羟基鸟嘌呤DNA糖基化酶1、谷胱甘肽S-转移酶M1和谷胱甘肽S-转移酶T1的基因型:膀胱癌临床预后的有用决定因素。
Urology. 2005 Jan;65(1):70-5. doi: 10.1016/j.urology.2004.08.005.
7
Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India.膀胱癌中GSTM1和GSTT1基因的多态性:来自印度北部的一项研究。
Arch Toxicol. 2004 Aug;78(8):430-4. doi: 10.1007/s00204-004-0559-y. Epub 2004 Apr 1.
8
The role of N-acetyltransferase-2 and glutathione S-transferase on the risk and aggressiveness of bladder cancer.N-乙酰转移酶-2和谷胱甘肽S-转移酶在膀胱癌风险和侵袭性方面的作用。
Anticancer Res. 2002 Nov-Dec;22(6B):3801-4.
9
Molecular prognosticators and genomic instability in papillary thyroid cancer.
Laryngoscope. 2005 Aug;115(8):1479-85. doi: 10.1097/01.mlg.0000172045.38907.52.
10
Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer.原发性非肌肉浸润性膀胱癌拓扑异构酶-IIα表达的临床意义及预后价值。
Urology. 2010 Jun;75(6):1516.e9-13. doi: 10.1016/j.urology.2009.08.055. Epub 2009 Nov 13.

引用本文的文献

1
GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer.GSTM1 组织基因型作为非肌肉浸润性膀胱癌的复发预测因子。
J Korean Med Sci. 2011 Feb;26(2):231-6. doi: 10.3346/jkms.2011.26.2.231. Epub 2011 Jan 24.